It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ELAN’s FA Score shows that 0 FA rating(s) are green whileHCM’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ELAN’s TA Score shows that 4 TA indicator(s) are bullish while HCM’s TA Score has 4 bullish TA indicator(s).
ELAN (@Pharmaceuticals: Other) experienced а -3.17% price change this week, while HCM (@Pharmaceuticals: Other) price change was -9.89% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.01%. For the same industry, the average monthly price growth was -7.82%, and the average quarterly price growth was -7.80%.
ELAN is expected to report earnings on Feb 19, 2025.
HCM is expected to report earnings on Nov 15, 2024.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
ELAN | HCM | ELAN / HCM | |
Capitalization | 7.87B | 2.88B | 273% |
EBITDA | -224M | 67.3M | -333% |
Gain YTD | -5.772 | -6.957 | 83% |
P/E Ratio | N/A | 27.95 | - |
Revenue | 4.42B | 838M | 527% |
Total Cash | 352M | 886M | 40% |
Total Debt | 5.77B | 86.1M | 6,706% |
ELAN | HCM | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 5 | 62 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 67 Overvalued | 92 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 94 | 43 | |
PRICE GROWTH RATING 1..100 | 57 | 79 | |
P/E GROWTH RATING 1..100 | 70 | 45 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ELAN's Valuation (67) in the Agricultural Commodities Or Milling industry is in the same range as HCM (92) in the Pharmaceuticals Major industry. This means that ELAN’s stock grew similarly to HCM’s over the last 12 months.
ELAN's Profit vs Risk Rating (100) in the Agricultural Commodities Or Milling industry is in the same range as HCM (100) in the Pharmaceuticals Major industry. This means that ELAN’s stock grew similarly to HCM’s over the last 12 months.
HCM's SMR Rating (43) in the Pharmaceuticals Major industry is somewhat better than the same rating for ELAN (94) in the Agricultural Commodities Or Milling industry. This means that HCM’s stock grew somewhat faster than ELAN’s over the last 12 months.
ELAN's Price Growth Rating (57) in the Agricultural Commodities Or Milling industry is in the same range as HCM (79) in the Pharmaceuticals Major industry. This means that ELAN’s stock grew similarly to HCM’s over the last 12 months.
HCM's P/E Growth Rating (45) in the Pharmaceuticals Major industry is in the same range as ELAN (70) in the Agricultural Commodities Or Milling industry. This means that HCM’s stock grew similarly to ELAN’s over the last 12 months.
ELAN | HCM | |
---|---|---|
RSI ODDS (%) | 2 days ago74% | 2 days ago72% |
Stochastic ODDS (%) | 2 days ago76% | 2 days ago73% |
Momentum ODDS (%) | 2 days ago55% | 2 days ago81% |
MACD ODDS (%) | 2 days ago69% | 2 days ago87% |
TrendWeek ODDS (%) | 2 days ago74% | 2 days ago81% |
TrendMonth ODDS (%) | 2 days ago66% | 2 days ago83% |
Advances ODDS (%) | 9 days ago0% | N/A |
Declines ODDS (%) | N/A | 2 days ago81% |
BollingerBands ODDS (%) | 2 days ago78% | 2 days ago80% |
Aroon ODDS (%) | 2 days ago78% | 2 days ago87% |
A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with TEVA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then TEVA could also see price increases.
Ticker / NAME | Correlation To ELAN | 1D Price Change % | ||
---|---|---|---|---|
ELAN | 100% | -1.06% | ||
TEVA - ELAN | 34% Loosely correlated | -1.12% | ||
PCRX - ELAN | 32% Poorly correlated | -0.49% | ||
PAHC - ELAN | 28% Poorly correlated | -1.46% | ||
TAK - ELAN | 27% Poorly correlated | +0.07% | ||
CTLT - ELAN | 26% Poorly correlated | -0.41% | ||
More |
A.I.dvisor tells us that HCM and KMDA have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HCM and KMDA's prices will move in lockstep.
Ticker / NAME | Correlation To HCM | 1D Price Change % | ||
---|---|---|---|---|
HCM | 100% | -1.12% | ||
KMDA - HCM | 21% Poorly correlated | -2.82% | ||
SIGA - HCM | 20% Poorly correlated | -4.69% | ||
ELAN - HCM | 20% Poorly correlated | -1.06% | ||
PBH - HCM | 20% Poorly correlated | +0.57% | ||
ZTS - HCM | 20% Poorly correlated | -1.36% | ||
More |